Results from Belimumab Safety Study
Lupus & Cognitive Dysfunction: No Apparent Link to Inflammation
Insight into the Downregulation of NK Cells in SLE Patients
Subcutaneous Belimumab Improves Systemic Lupus Srythematosus Outcomes
New Study Examines Treatment Options for Incomplete Lupus Erythematous
Professor Shares Findings from 45 Years of Lupus Research
SLE Remission: The Treat-to-Target Approach
Updates on Managing Lupus Complications
Diagnostic Challenges of SLE & Celiac Sprue
- 1
- 2
- 3
- …
- 8
- Next Page »